company logo

Sr HR Business Partner in South San Francisco, CA

Myriad Genetics, Inc

South San Francisco, CA 94080
7w ago


$100K - $150K*


HR Generalists & Business Partners


8 - 10 years

Job Description


  • Strategic Business Partner for the leaders in our SSF location, including Myriad Women's Health, Autoimmune and Technology. Partner with senior business leaders in support of their overall client group(s) through developing solutions to a variety of complex problems and initiatives exercising significant judgment on complex issues that support Myriad's business objectives. The HRBP is the initial point of contact for the majority of strategic HR support requests for the SSF client groups and has responsibility for evaluating and ensuring effective risk management relative to the organization's employee relations and human resource practices.
  • Organization Effectiveness: The HRBP will apply strong technical expertise (such as Organization Design, Employee Engagement, Workforce Planning, Change Management), knowledge of the business and environment, and situation specific analysis developing new concepts, techniques, and standards (from concept to
See More

Valid through: 2020-3-4

About Myriad Genetics

Myriad Genetics, Inc. is an American molecular diagnostic company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new molecular diagnostic products that assess an individuals risk for developing disease later in life (predictive medicine), identify a patients likelihood of responding to a particular drug therapy (personalized medicine), assess a patients risk of disease progression and disease recurrence (personalized medicine), and measure disease activity. Myriads discovery of the breast cancer gene, BRCA1 was universally acclaimed as a monumental achievement: “There is no more exciting story in medical science.” Myriad was the subject of scrutiny after it became involved in a lawsuit over its patenting practices, which led to the landmark Supreme Court decision Association for Molecular Pathology v. Myriad Genetics. In August 2016 Myriad announced it would acquire Assurex Health for up to $410 million, expanding the companys genetic testing for psychotropic medicine selection. The global search for the genetic basis of breast and ovarian cancers began in earnest in 1988. In 1990, at an American Society of Human Genetics Meeting, a team of scientists led by Mary-Claire King, Ph.D., from University of California, Berkeley announced the localization through linkage analysis of a gene associated with increased risk for breast cancer (BRCA1) to the long arm of chromosome 17. In August 1994, Mark Skolnick and researchers at Myriad, along with colleagues at the University of Utah, the U.S National Institutes of Health (NIH), and McGill University sequenced BRCA1. In 2013, the actress Angelina Jolie had her ovaries removed because she tested positive for a mutation in the BRCA1 gene. This led to a surge in demand by women for genetic testing.
Total Jobs:
Total Experts:
Average Pay:
Total value of jobs:
% Masters:

Myriad Genetics Photos

company social media photocompany social media photocompany social media photocompany social media photo
* Ladders Estimates